Ma Y - Search Results

1

Frequency, clinical features and differential response to therapy of concurrent ALK/EGFR alterations in Chinese lung cancer patients.

Liu J, Mu Z, Liu L, Li K, Jiang R, Chen P, Zhou Q, Jin M, Ma Y, Xie Y, Xiang J, Li B, Ma Y, Mao X, Zhang L, Zhang T, Wu D. Liu J, et al. Among authors: ma y. Drug Des Devel Ther. 2019 May 23;13:1809-1817. doi: 10.2147/DDDT.S196189. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31213769 Free PMC article.

2

[The cost-effectiveness analysis of gefitinib or erlotinib in the treatment of advanced EGFR mutant non-small cell lung cancer patients].

Ma Y, Huang Y, Zhao H, Liu J, Chen L, Wu H, Zhou N. Ma Y, et al. Zhongguo Fei Ai Za Zhi. 2013 Apr;16(4):203-10. doi: 10.3779/j.issn.1009-3419.2013.04.06. Zhongguo Fei Ai Za Zhi. 2013. PMID: 23601301 Free PMC article. Chinese.

3

The impact of both platinum-based chemotherapy and EGFR-TKIs on overall survival of patients with advanced non-small cell lung cancer.

Zhang JW, Zhao YY, Guo Y, Xue C, Hu ZH, Huang Y, Zhao HY, Zhang J, Wu X, Fang WF, Ma YX, Zhang L. Zhang JW, et al. Among authors: ma yx. Chin J Cancer. 2014 Feb;33(2):105-14. doi: 10.5732/cjc.012.10274. Epub 2013 Jul 2. Chin J Cancer. 2014. PMID: 23816558 Free PMC article.

4

Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutations.

Liang W, Wu X, Fang W, Zhao Y, Yang Y, Hu Z, Xue C, Zhang J, Zhang J, Ma Y, Zhou T, Yan Y, Hou X, Qin T, Dinglin X, Tian Y, Huang P, Huang Y, Zhao H, Zhang L. Liang W, et al. Among authors: ma y. PLoS One. 2014 Feb 12;9(2):e85245. doi: 10.1371/journal.pone.0085245. eCollection 2014. PLoS One. 2014. PMID: 24533047 Free PMC article.

5

A large-scale cross-sectional study of ALK rearrangements and EGFR mutations in non-small-cell lung cancer in Chinese Han population.

Hong S, Fang W, Hu Z, Zhou T, Yan Y, Qin T, Tang Y, Ma Y, Zhao Y, Xue C, Huang Y, Zhao H, Zhang L. Hong S, et al. Among authors: ma y. Sci Rep. 2014 Dec 1;4:7268. doi: 10.1038/srep07268. Sci Rep. 2014. PMID: 25434695 Free PMC article.

6

The efficacy of first-line chemotherapy is associated with KRAS mutation status in patients with advanced non-small cell lung cancer: a meta-analysis.

Zhang Y, Fang W, Yan Y, Wang M, Kang S, Sheng J, Zhan J, Chen N, Hong S, Yang Y, Ma Y, He D, Qin T, Zhou T, Tang Y, He X, Liang W, Zhang L. Zhang Y, et al. Among authors: ma y. Med Oncol. 2015 Mar;32(3):61. doi: 10.1007/s12032-015-0489-y. Epub 2015 Feb 8. Med Oncol. 2015. PMID: 25663066

7

The efficacy of combining antiangiogenic agents with chemotherapy for patients with advanced non-small cell lung cancer who failed first-line chemotherapy: a systematic review and meta-analysis.

Sheng J, Yang Y, Ma Y, Yang B, Zhang Y, Kang S, Zhou T, Hong S, Qin T, Hu Z, Fang W, Huang Y, Zhang L. Sheng J, et al. Among authors: ma y. PLoS One. 2015 Jun 2;10(6):e0127306. doi: 10.1371/journal.pone.0127306. eCollection 2015. PLoS One. 2015. PMID: 26034985 Free PMC article.

8

The Dissociation of Gefitinib Trough Concentration and Clinical Outcome in NSCLC Patients with EGFR Sensitive Mutations.

Xin S, Zhao Y, Wang X, Huang Y, Zhang J, Guo Y, Li J, Li H, Ma Y, Chen L, Hu Z, Huang M, Zhang L. Xin S, et al. Among authors: ma y. Sci Rep. 2015 Jul 31;5:12675. doi: 10.1038/srep12675. Sci Rep. 2015. PMID: 26228025 Free PMC article.

9

The Efficacy of Combining EGFR Monoclonal Antibody With Chemotherapy for Patients With Advanced Nonsmall Cell Lung Cancer: A Meta-Analysis From 9 Randomized Controlled Trials.

Sheng J, Yang YP, Zhao YY, Qin T, Hu ZH, Zhou T, Zhang YX, Hong SD, Ma YX, Zhao HY, Huang Y, Zhang L. Sheng J, et al. Among authors: ma yx. Medicine (Baltimore). 2015 Aug;94(34):e1400. doi: 10.1097/MD.0000000000001400. Medicine (Baltimore). 2015. PMID: 26313787 Free PMC article. Review.

10

Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs.

Sheng J, Yang YP, Ma YX, Qin T, Hu ZH, Hong SD, Zhou T, Huang Y, Zhao HY, Zhang L. Sheng J, et al. Among authors: ma yx. PLoS One. 2016 Jan 19;11(1):e0147226. doi: 10.1371/journal.pone.0147226. eCollection 2016. PLoS One. 2016. PMID: 26784943 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39,993 results

Search Page